Northwest Bio

We are a biotech company developing personalized immune therapies (DCVax®) to treat solid tumor cancers.

[Northwest Bio @NorthwestBio]

Can’t attend? Watch the webcast at https://t.co/J6XtGOvlao.

[Northwest Bio @NorthwestBio]

Join @NorthwestBio on Sunday, June 3, at 4:15 (CT) at #ASCO2018 as Dr. Marnix L. Bosch, Chief Technical Officer of NW Bio, will discuss the interim data that was published on May 29 from the Company’s Phase 3 trial of DCVax®-L for newly diagnosed #Glioblastoma brain #cancer.

[Northwest Bio @NorthwestBio]

.@NorthwestBio Announces Scientific Publication of Interim Survival Data From Phase 3 Trial of DCVax®-L for #Glioblastoma Brain #Cancer. https://t.co/HsLoKrBuMV

[Northwest Bio @NorthwestBio]

The Poster & accompanying presentation will be posted on the $NWBO website following the presentation at http://t.co/Y8n7GUIKME #DCVax

[Northwest Bio @NorthwestBio]

$NWBO presentation at Int'l Cancer Immunotherapy Conference will be presented in the 6:45-8:45pm ET Session A today http://t.co/GL1UoPyddV

[Northwest Bio @NorthwestBio]

$NWBO CTO Dr. Marnix Bosch to present a new DCVax-Direct poster at Inaugural Int'l Cancer Immunotherapy Conference http://t.co/MjnOC1k3jV

[Northwest Bio @NorthwestBio]

$NWBO to Present at 4th Annual @SMIpharm Cancer Vaccines Conference in London Today at 1:30pm BST (8:30am ET) http://t.co/nVb3nByy2O #DCVAX

[Northwest Bio @NorthwestBio]

Press Release: NW Bio Confirms Phase III Trial of DCVax®-L for GBM Brain Cancer Is Ongoing http://t.co/22IA1nZGGN $NWBO #NWBO

[Northwest Bio @NorthwestBio]

Promising new data on Phase I trial of DCVax-Direct for direct injection into all types of inop. solid tumors http://t.co/2vF28tFpdM $NWBO

[Northwest Bio @NorthwestBio]

Findings to date from $NWBO's DCVax-Direct Phase I trial relating to immunological responses include the following: http://t.co/mfLZf0NVQG

[Northwest Bio @NorthwestBio]

$NWBO looks forward to proceeding w/ Phase II trials applying lessons learned from this informative Phase I trial http://t.co/89vN0225T4

[Northwest Bio @NorthwestBio]

Data to date from DCVax-direct Phase I trial: 86% of Phase I patients treated w/ preferred method still alive http://t.co/6fPYKDHluU $NWBO

[Northwest Bio @NorthwestBio]

ICYMI: Watch Dr. Marnix L. Bosch give an overview of $NWBO's #DCVax direct Phase 1 trial here: http://t.co/a98Y3TiW2A #ASCO15

[Northwest Bio @NorthwestBio]

Press Release: $NWBO Announces Data to Date From #DCVax-Direct Phase I Trial http://t.co/JVTjImNY7c #cancer

[Northwest Bio @NorthwestBio]

Great Industry Expert Theater Presentation by Dr. Marnix Bosch, CTO at $NWBO today. #ASCO15

[Northwest Bio @NorthwestBio]

Happy to be at #ASCO15 - stop by and see us!

[Northwest Bio @NorthwestBio]

Check out Dr. Marnix Bosch's presentation @NYASEvents' conference on emerging approaches to #immunotherapy: http://t.co/TjZerN7SMl $NWBO

[Northwest Bio @NorthwestBio]

.@NYASEvents' conference on emerging approaches to immunotherapy, $NWBO's Dr. Marnix Bosch will discuss #DCVax-Direct http://t.co/Wc0bbuvm5R

[Northwest Bio @NorthwestBio]

$NWBO to present at @NYASEvents' conference on emerging approaches to #immunotherapy today. Learn more: http://t.co/Lk3zTxzaDk

[Northwest Bio @NorthwestBio]

Tomorrow, Linda Powers, $NWBO CEO, will present a live overview of our #DCVax cancer vaccine platform. Learn more: http://t.co/ziYejBCU0h